HIGHLIGHTS
- who: Staci L. Haney and Sarah A. Holstein from the Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, NE, USA have published the research: Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma, in the Journal: (JOURNAL)
- what: Multiple myeloma remains an incurable disease and novel treatment options are urgently needed.
- future: Such findings suggest that association between statin treatment and MM risk varies by both exposure window and patient age and further investigation is needed to understand this connection.
SUMMARY
Statins deplete the downstream . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.